FDA Approves Egalet’s Morphine Tablet, But with a Narrower Abuse-Deterrent Label

Drug Industry Daily
A A
The FDA approved Egalet’s extended-release morphine tablet, Arymo ER, for daily, around-the-clock pain treatment, with specific labeling describing physical properties that can deter abuse through injection.

To View This Article:

Login

Subscribe To Drug Industry Daily